GPTHEALTH

GPT Healthcare Limited

Healthcare services provider in hospitals and diagnostics

Healthcare›Healthcare›Healthcare Services›Hospital

gptgroup.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹140.74
Market cap
1,156 Cr
Stock P/E
24.5
P/B
4.27
Dividend yield
1.8%
ROE (FY22)
26.4%
ROCE (FY22)
25.7%
Operating margin (FY22)
17.9%
Debt / equity (FY22)
0.60
OCF / EBITDA (FY26)
96.4%
OCF / EBITDA (3Y)
85.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

GPT Healthcare runs private tertiary-care hospitals, mainly in Eastern India, for patients who pay in cash or through insurance.

Company snapshot

22ndBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓Revenue grew 39% in the latest year — strong top-line momentum.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales97 Cr99 Cr98 Cr106 Cr102 Cr101 Cr107 Cr119 Cr120 Cr126 Cr126 Cr
Operating expenses (approx.)76 Cr76 Cr80 Cr82 Cr81 Cr81 Cr90 Cr96 Cr99 Cr103 Cr102 Cr
EBITDA21 Cr23 Cr18 Cr23 Cr21 Cr21 Cr17 Cr23 Cr21 Cr23 Cr24 Cr
OPM %21.7%23.3%18.4%22.2%20.8%20.4%16.2%19.1%17.2%18.5%19.2%
Other income1 Cr2 Cr2 Cr3 Cr2 Cr2 Cr2 Cr1 Cr1 Cr2 Cr2 Cr
Interest2 Cr2 Cr0.86 Cr0.74 Cr0.85 Cr1 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Depreciation5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr6 Cr7 Cr7 Cr7 Cr7 Cr
Profit before tax16 Cr18 Cr15 Cr21 Cr18 Cr16 Cr11 Cr15 Cr13 Cr16 Cr17 Cr
Tax %28.3%30.4%32.1%28.4%30.5%21.3%30.9%29.6%26.6%8.2%25.8%
Net profit11 Cr13 Cr10 Cr15 Cr12 Cr13 Cr8 Cr11 Cr9 Cr15 Cr13 Cr
EPS (₹)₹1.44₹1.59₹1.21₹1.81₹1.49₹1.57₹0.94₹1.29₹1.14₹1.78₹1.55

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales243 Cr337 Cr361 Cr400 Cr407 Cr473 CrSign in free for the trailing twelve months
Operating expenses (approx.)194 Cr264 Cr287 Cr312 Cr324 Cr388 CrSign in free for the trailing twelve months
EBITDA49 Cr74 Cr74 Cr88 Cr83 Cr84 CrSign in free for the trailing twelve months
OPM %20.2%21.9%20.6%21.9%20.5%17.8%Sign in free for the trailing twelve months
Other income6 Cr5 Cr6 Cr5 Cr8 Cr6 CrSign in free for the trailing twelve months
Interest14 Cr11 Cr9 Cr7 Cr3 Cr8 CrSign in free for the trailing twelve months
Depreciation12 Cr14 Cr15 Cr18 Cr19 Cr27 CrSign in free for the trailing twelve months
Profit before tax29 Cr54 Cr56 Cr68 Cr69 Cr55 CrSign in free for the trailing twelve months
Tax %27.0%23.0%30.3%29.8%28.0%23.0%Sign in free for the trailing twelve months
Net profit21 Cr42 Cr39 Cr48 Cr50 Cr42 CrSign in free for the trailing twelve months
EPS (₹)₹2.64₹5.21₹4.88₹5.96₹6.08₹5.15Sign in free for the trailing twelve months
Dividend payout %———50.2%57.5%48.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital18 Cr80 Cr80 Cr82 Cr82 Cr82 Cr
Reserves116 Cr78 Cr85 Cr136 Cr166 Cr187 Cr
Borrowings123 Cr96 Cr65 Cr12 Cr13 Cr16 Cr
Other liabilities60 Cr70 Cr97 Cr115 Cr123 Cr179 Cr
Total liabilities317 Cr323 Cr327 Cr346 Cr384 Cr465 Cr
Fixed assets (net)212 Cr207 Cr204 Cr201 Cr203 Cr265 Cr
CWIP0.29 Cr0.72 Cr3 Cr6 Cr46 Cr0.71 Cr
Investments0.71 Cr10 Cr13 Cr30 Cr32 Cr43 Cr
Loans & advances———11 Cr0.17 Cr1 Cr
Inventories6 Cr7 Cr9 Cr8 Cr9 Cr11 Cr
Trade receivables17 Cr13 Cr21 Cr24 Cr25 Cr20 Cr
Cash & bank5 Cr8 Cr7 Cr2 Cr2 Cr4 Cr
Other assets76 Cr77 Cr71 Cr62 Cr68 Cr119 Cr
Total assets317 Cr323 Cr327 Cr346 Cr384 Cr465 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity44 Cr66 Cr66 Cr69 Cr67 Cr81 Cr
Cash from investing-17 Cr-5 Cr5 Cr-25 Cr-33 Cr-47 Cr
Cash from financing-22 Cr-57 Cr-73 Cr-49 Cr-35 Cr-31 Cr
Net cash flow4 Cr3 Cr-2 Cr-5 Cr-0.03 Cr2 Cr
Free cash flow (OCF − Capex)37 Cr59 Cr57 Cr49 Cr17 Cr39 Cr

Ratios

MetricMar 2021Mar 2022
ROCE %16.6%25.7%
ROE %15.8%26.4%
Debtor days2614
Inventory days4130
Days payable165121
Cash conversion cycle-98-76
OCF / EBITDA %87.8%89.4%
Debt / equity0.920.60
Current ratio1.441.25
Net debt / EBITDA2.411.18